Alpha 2.0
Login Register
» Authors » Kaggwa Mugagga

Kaggwa Mugagga

Explore the profile of Kaggwa Mugagga including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 46
Followers 0
Related Specialties
General Medicine
Public Health
Health Services
Top 10 Co-Authors
Claude Wandera
Andrew Kambugu
Jacinto Amandua
Emmanuel Seremba
Alex Muganzi
Philippa Easterbrook
Ponsiano Ocama
Pontiano Kaleebu
Rachel Beyagira
Joshua Musinguzi
Published In
PLoS One
BMC Med Educ
BMC Public Health
BMJ Open
J Antimicrob Chemother
Affiliations
Soon will be listed here.
Recent Articles
1.
Feasibility and acceptability of integrating hepatitis B care into routine HIV services: a qualitative study among health care providers and patients in West Nile region, Uganda
Mutyoba J, Wandera C, Ejalu D, Seremba E, Beyagira R, Amandua J, et al.
BMC Health Serv Res . 2023 Jan; 23(1):59. PMID: 36670448
Background: Despite facing a dual burden of HBV and HIV, Africa lacks experience in offering integrated care for HIV and HBV. To contextualize individual and group-level feasibility and acceptability of...
2.
Integrating hepatitis B care and treatment with existing HIV services is possible: cost of integrated HIV and hepatitis B treatment in a low-resource setting: a cross-sectional hospital-based cost-minimisation assessment
Ejalu D, Mutyoba J, Wandera C, Seremba E, Kambugu A, Muganzi A, et al.
BMJ Open . 2022 Jul; 12(7):e058722. PMID: 35777868
Background: Hepatitis B and HIV care share health system challenges in the implementation of primary prevention, screening, early linkage to care, monitoring of therapeutic success and long-term medication adherence. Setting:...
3.
A training for health care workers to integrate hepatitis B care and treatment into routine HIV care in a high HBV burden, poorly resourced region of Uganda: the '2for1' project
Nankya-Mutyoba J, Ejalu D, Wandera C, Beyagira R, Amandua J, Seremba E, et al.
BMC Med Educ . 2022 Apr; 22(1):297. PMID: 35443646
Introduction: The "2for1" project is a demonstration project to examine the feasibility and effectiveness of HBV care integrated into an HIV clinic and service. An initial phase in implementation of...
4.
HIV drug resistance among adults initiating antiretroviral therapy in Uganda
Watera C, Ssemwanga D, Namayanja G, Asio J, Lutalo T, Namale A, et al.
J Antimicrob Chemother . 2021 May; 76(9):2407-2414. PMID: 33993252
Background: WHO revised their HIV drug resistance (HIVDR) monitoring strategy in 2014, enabling countries to generate nationally representative HIVDR prevalence estimates from surveys conducted using this methodology. In 2016, we...
5.
Households experiencing catastrophic costs due to tuberculosis in Uganda: magnitude and cost drivers
Muttamba W, Tumwebaze R, Mugenyi L, Batte C, Sekibira R, Nkolo A, et al.
BMC Public Health . 2020 Sep; 20(1):1409. PMID: 32938411
Background: Tuberculosis (TB) patients in Uganda incur large costs related to the illness, and while seeking and receiving health care. Such costs create access and adherence barriers which affect health...
6.
Population-based monitoring of HIV drug resistance early warning indicators in Uganda: A nationally representative survey following revised WHO recommendations
Asio J, Watera C, Namuwenge N, Kirungi W, Musinguzi J, Mugagga K, et al.
PLoS One . 2020 Apr; 15(4):e0230451. PMID: 32287264
Introduction: With the scale-up of antiretroviral therapy (ART) there is a need to monitor programme performance to maximize ART efficacy and to prevent emergence of HIV drug resistance (HIVDR). In...